| Emerging roles of long non-coding RNA in cancer |
106 |
| Regulatory T (Treg) cells in cancer: Can Treg cells be a new therapeutic target? |
49 |
| NRF2 addiction in cancer cells |
46 |
| Exosomes in cancer development and clinical applications |
44 |
| Immune infiltration in renal cell carcinoma |
37 |
| PD-L1 expression is mainly regulated by interferon gamma associated with JAK-STAT pathway in gastric cancer |
36 |
| Podoplanin: An emerging cancer biomarker and therapeutic target |
33 |
| Tumor-suppressive circular RNAs: Mechanisms underlying their suppression of tumor occurrence and use as therapeutic targets |
31 |
| Hypoxia/pseudohypoxia-mediated activation of hypoxia-inducible factor-1 in cancer |
31 |
| Development of miRNA-based therapeutic approaches for cancer patients |
31 |
| Circulating miRNA panels for specific and early detection in bladder cancer |
29 |
| Preclinical characterization of anlotinib, a highly potent and selective vascular endothelial growth factor receptor-2 inhibitor |
29 |
| Feasibility and utility of a panel testing for 114 cancer-associated genes in a clinical setting: A hospital-based study |
29 |
| Mitochondrial network structure homeostasis and cell death |
26 |
| Immunomodulatory activity of lenvatinib contributes to antitumor activity in the Hepa1-6 hepatocellular carcinoma model |
24 |
| LUCAT1 promotes colorectal cancer tumorigenesis by targeting the ribosomal protein L40-MDM2-p53 pathway through binding with UBA52 |
24 |
| Association of antithyroglobulin antibodies with the development of thyroid dysfunction induced by nivolumab |
24 |
| Hispidulin suppresses cell growth and metastasis by targeting PIM1 through JAK2/STAT3 signaling in colorectal cancer (Retracted article. See vol. pg. 2020) |
24 |
| Thymoquinone inhibits the metastasis of renal cell cancer cells by inducing autophagy via AMPK/mTOR signaling pathway |
23 |
| Dormancy in cancer |
23 |
| The immune response-related mutational signatures and driver genes in non-small-cell lung cancer |
23 |
| Whole genome sequencing analysis for cancer genomics and precision medicine |
22 |
| Tumor suppressive role for kinases phosphorylating p53 in DNA damage-induced apoptosis |
22 |
| Wnt signaling in human and mouse breast cancer: Focusing on Wnt ligands, receptors and antagonists |
22 |
| Significance of tumor-infiltrating lymphocytes before and after neoadjuvant therapy for rectal cancer |
21 |
| Targeted exosome-encapsulated erastin induced ferroptosis in triple negative breast cancer cells |
21 |
| Long non-coding RNA NEAT1 promoted ovarian cancer cells' metastasis through regulation of miR-382-3p/ROCK1 axial |
21 |
| Langerhans cell histiocytosis in adults: Advances in pathophysiology and treatment |
20 |
| Exosome-mediated regulation of tumor immunology |
20 |
| MicroRNAs as potential biomarkers for the diagnosis of glioma: A systematic review and meta-analysis |
20 |
| Circular RNA circCRIM1 inhibits invasion and metastasis in lung adenocarcinoma through the microRNA (miR)-182/miR-93-leukemia inhibitory factor receptor pathway |
19 |
| circMAN1A2 could serve as a novel serum biomarker for malignant tumors |
19 |
| Regulatory mechanisms of hypoxia-inducible factor 1 activity: Two decades of knowledge |
19 |
| Regulation of antitumor miR-144-5p targets oncogenes: Direct regulation of syndecan-3 and its clinical significance |
19 |
| Exosomes serve as nanoparticles to suppress tumor growth and angiogenesis in gastric cancer by delivering hepatocyte growth factor siRNA |
18 |
| LncRNA MIR22HG inhibits growth, migration and invasion through regulating the miR-10a-5p/NCOR2 axis in hepatocellular carcinoma cells |
18 |
| MicroRNA-331-3p inhibits epithelial-mesenchymal transition by targeting ErbB2 and VAV2 through the Rac1/PAK1/beta-catenin axis in non-small-cell lung cancer |
18 |
| CD47-signal regulatory protein signaling system and its application to cancer immunotherapy |
18 |
| Xanthohumol inhibits angiogenesis by suppressing nuclear factor-kappa B activation in pancreatic cancer |
18 |
| Downregulation of miR-491-5p promotes gastric cancer metastasis by regulating SNAIL and FGFR4 |
18 |
| PRMT9 promotes hepatocellular carcinoma invasion and metastasis via activating PI3K/Akt/GSK-3/Snail signaling |
18 |
| Long non-coding RNA FOXD2-AS1 contributes to colorectalcancer proliferation through its interaction withmicroRNA-185-5p |
17 |
| AC016405. a novel long noncoding RNA, acts as a tumor suppressor through modulation of TET2 by microRNA-19a-5p sponging in glioblastoma |
17 |
| RK-28 a potent and specific tankyrase inhibitor, blocks colorectal cancer cell growth in a preclinical model |
17 |
| Exosomal zinc transporter ZIP4 promotes cancer growth and is a novel diagnostic biomarker for pancreatic cancer |
17 |
| Pembrolizumab in Asia-Pacific patients with advanced head and neck squamous cell carcinoma: Analyses from KEYNOTE-012 |
16 |
| Chemokine (C-X-C motif) ligand 1 and CXCL2 produced by tumor promote the generation of monocytic myeloid-derived suppressor cells |
16 |
| Exosomal microRNAs derived from colon cancer cells promote tumor progression by suppressing fibroblast TP53 expression |
16 |
| Oncogenic Y-box binding protein-1 as an effective therapeutic target in drug-resistant cancer |
16 |
| HOTAIR, a long noncoding RNA, is a marker of abnormal cell cycle regulation in lung cancer |
16 |
